Get the Stockscreener App
0.7846
1.99%
0.0153
Neuroone Medical Technologies Corp stock is traded at $0.7846, with a volume of 137.17K.
It is up +1.99% in the last 24 hours and down -23.83% over the past month.
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.
See More
Previous Close:
$0.7693
Open:
$0.777
24h Volume:
137.17K
Relative Volume:
0.60
Market Cap:
$39.23M
Revenue:
$2.82M
Net Income/Loss:
$-13.47M
P/E Ratio:
-1.1538
EPS:
-0.68
Net Cash Flow:
$-13.61M
1W Performance:
-4.29%
1M Performance:
-23.83%
6M Performance:
-31.77%
1Y Performance:
-0.68%
1-Day Range:
$0.7614
$0.80
1-Week Range:
$0.73
$1.01
52-Week Range:
$0.3954
$1.39
Neuroone Medical Technologies Corp Stock (NMTC) Company Profile
Name
Neuroone Medical Technologies Corp
Sector
Industry
Phone
(952) 426-1383
Address
7599 ANAGRAM DR, EDEN PRAIRIE
Compare NMTC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 0.99 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
0.92 | 1.26B | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.58 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
2.53 | 110.24M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.1668 | 351.80M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
1.24 | 0 | 0 | 0 | 0 | 0.00 |
Neuroone Medical Technologies Corp Stock (NMTC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-05-25 | Initiated | Ladenburg Thalmann | Buy |
| Mar-29-22 | Downgrade | Craig Hallum | Buy → Hold |
Neuroone Medical Technologies Corp Stock (NMTC) Latest News
Is NeuroOne Medical Technologies Corporation stock ready for a breakout2025 Price Targets & Long-Term Investment Growth Plans - Newser
Can you recover from losses in NeuroOne Medical Technologies CorporationJuly 2025 Drop Watch & Real-Time Volume Analysis - Newser
Real time alert setup for NeuroOne Medical Technologies Corporation performance2025 Volume Leaders & Technical Analysis for Trade Confirmation - Newser
What recovery options are there for NeuroOne Medical Technologies CorporationPortfolio Performance Report & High Return Trade Guides - Newser
NMTC Stock Gains as FDA Clears OneRF System for Facial Pain Treatment - Yahoo Finance
Does NeuroOne Medical Technologies Corporation qualify in momentum factor screeningInsider Selling & Fast Gain Swing Alerts - Newser
NeuroOne’s nerve ablation system secures FDA clearance - Yahoo Finance
Published on: 2025-08-19 04:28:57 - Newser
Market reaction to NeuroOne Medical Technologies Corporation’s recent news2025 Institutional Moves & Verified Swing Trading Watchlists - Newser
Is NeuroOne Medical Technologies Corporation reversing from oversold territoryMarket Volume Summary & Free Verified High Yield Trade Plans - Newser
What makes NeuroOne Medical Technologies Corporation stock price move sharplyProduct Launch & Real-Time Stock Movement Alerts - Newser
NeuroOne Medical Technologies receives FDA clearance for OneRF system - Investing.com
First-of-its-Kind Pain Treatment: NeuroOne's OneRF System Gets FDA Green Light for 150K Facial Pain Patients - Stock Titan
Analyzing recovery setups for NeuroOne Medical Technologies Corporation investorsJuly 2025 Sector Moves & Real-Time Volume Surge Alerts - Newser
Is NeuroOne Medical Technologies Corporation stock entering bullish territoryWeekly Earnings Recap & Verified Momentum Stock Alerts - Newser
What the charts say about NeuroOne Medical Technologies Corporation todayWeekly Trade Review & AI Enhanced Market Trend Forecasts - Newser
What technical models suggest about NeuroOne Medical Technologies Corporation’s comebackStop Loss & Weekly High Potential Stock Alerts - Newser
NeuroOne Medical Technologies Third Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Reversal indicators forming on NeuroOne Medical Technologies Corporation stockJuly 2025 Retail & Risk Adjusted Buy/Sell Alerts - Newser
Using fundamentals and technicals on NeuroOne Medical Technologies CorporationTrend Reversal & Safe Capital Growth Trade Ideas - Newser
NeuroOne Medical Technologies' $8.0M Share Sale: A Strategic Move to Fuel Innovation and Secure Long-Term Growth - AInvest
NeuroOne Medical Technologies files updated $6.75 million at-the-market offering - Investing.com Australia
NeuroOne Medical Technologies files updated $6.75 million at-the-market offering By Investing.com - Investing.com South Africa
Does NeuroOne Medical Technologies Corporation show high probability of reboundTrade Exit Report & Comprehensive Market Scan Insights - Newser
NeuroOne Q3 Revenue Jumps 105 Percent - AOL.com
NeuroOne Medical Technologies Corp Exceeds Q3 FY2025 Earnings Estimates with 105% Increase in Product Revenue - AInvest
NeuroOne (NMTC) Q3 2025 Earnings Call Transcript - AOL.com
NeuroOne Q3 Revenue Jumps 105 Percent - The Motley Fool
NeuroOne Medical Technologies Corporation shares fall 2.33% intraday after Q3 2025 financial results conference call. - AInvest
NeuroOne Medical (NMTC): A High-Conviction Long-Term Play in Med-Tech Innovation - AInvest
NeuroOne Medical Technologies Corporation Q3 2025 Earnings Call Transcript: Financial Progress and Product Advancements - AInvest
NeuroOne's Q3 2025 Earnings Call: Key Contradictions in Product Development, Revenue, and FDA Pathways - AInvest
Earnings call transcript: NeuroOne Medical Q3 2025 beats revenue expectations - Investing.com Canada
NEUROONE MEDICAL TECHNOLOGIES Corp SEC 10-Q Report - TradingView
NeuroOne Reports Strong Q3 FY2025 Financial Results - TradingView
NeuroOne reports Q3 FY25 rev. $1.7 mln, up 105% YoY, completes $8.2 mln capital raise. - AInvest
NeuroOne Medical Technologies Corp expected to post a loss of 5 cents a shareEarnings Preview - TradingView
NeuroOne Medical NMTC Q3 2025 Earnings Preview Upside Potential Driven by FDA Approvals and Strategic Partnerships - AInvest
Why NeuroOne Medical Technologies Corporation stock attracts strong analyst attentionFree Short Term Buy Zone Stock Alerts - Newser
Exit strategy if you’re trapped in NeuroOne Medical Technologies Corporation - Newser
Can NeuroOne Medical Technologies Corporation hit a new high this monthReal Time Screener for Growth Trades - Newser
Published on: 2025-08-10 05:12:13 - Newser
Published on: 2025-08-08 23:32:40 - Newser
NeuroOne Medical Technologies Corporation stock retracement – recovery analysisAI Screener for Daily Stock Forecast - Newser
Why NeuroOne Medical Technologies Corporation is moving todayPrice Action Trading with Volume Confirmation - Newser
Neuroone Medical Technologies Corp Stock (NMTC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Neuroone Medical Technologies Corp Stock (NMTC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Christianson Mark | Business Development Director |
Jun 04 '25 |
Sale |
0.58 |
10,000 |
5,804 |
261,491 |
| Christianson Mark | Business Development Director |
May 22 '25 |
Sale |
0.62 |
8,967 |
5,586 |
271,491 |
| Christianson Mark | Business Development Director |
May 21 '25 |
Sale |
0.65 |
14 |
9 |
280,458 |
| Christianson Mark | Business Development Director |
May 19 '25 |
Sale |
0.67 |
8,006 |
5,330 |
283,485 |
| Christianson Mark | Business Development Director |
May 20 '25 |
Sale |
0.66 |
3,013 |
1,976 |
280,472 |
| McClurg Ronald W. | Chief Financial Officer |
Apr 04 '25 |
Buy |
0.50 |
200,000 |
100,000 |
444,117 |
| Rosa David A | CEO and President |
Apr 04 '25 |
Buy |
0.50 |
100,000 |
50,000 |
1,161,289 |
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):